BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11734740)

  • 21. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.
    Dayan GH; Panero MS; Debbag R; Urquiza A; Molina M; Prieto S; Del Carmen Perego M; Scagliotti G; Galimberti D; Carroli G; Wolff C; Schmid DS; Loparev V; Guris D; Seward J
    J Clin Microbiol; 2004 Dec; 42(12):5698-704. PubMed ID: 15583301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
    Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of varicella-zoster virus immunoglobulin G antibodies in fingerstick blood.
    Vafai N; Self K; Sheffield B; Hojvat S; Kusi-Appiah A; Vaughan P; Cowan E; Vafai A
    J Immunol Methods; 2023 Mar; 514():113429. PubMed ID: 36690067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.
    Han SB; Kang KR; Huh DH; Lee HC; Kim JH; Kang JH; Ma SH
    Epidemiol Infect; 2015 Jun; 143(8):1643-50. PubMed ID: 25234331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.
    Amjadi O; Rafiei A; Haghshenas M; Navaei RA; Valadan R; Hosseini-Khah Z; Omran AH; Arabi M; Shakib RJ; Mousavi T; Ashrafi GH
    J Clin Virol; 2017 Feb; 87():49-59. PubMed ID: 28011413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
    Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
    J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data.
    Aebi C; Fischer K; Gorgievski M; Matter L; Mühlemann K
    Vaccine; 2001 Apr; 19(23-24):3097-103. PubMed ID: 11312004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea.
    Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW
    Int J Infect Dis; 2008 May; 12(3):245-7. PubMed ID: 17950022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing.
    Vilibic-Cavlek T; Ljubin-Sternak S; Kolaric B; Kaic B; Sviben M; Kos L; Mlinaric-Galinovic G
    Arch Gynecol Obstet; 2012 Oct; 286(4):901-4. PubMed ID: 22678561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate.
    O'Grady KA; Merianos A; Patel M; Gilbert L
    Trop Med Int Health; 2000 Oct; 5(10):732-6. PubMed ID: 11044268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
    Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
    J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of antibodies against varicella zoster virus and rubella virus among newly recruited expatriate healthcare workers: a cross-sectional study.
    Shady I
    BMJ Open; 2018 Mar; 8(3):e019339. PubMed ID: 29567844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.
    Maple PA; Haedicke J; Quinlivan M; Steinberg SP; Gershon AA; Brown KE; Breuer J
    Epidemiol Infect; 2016 Aug; 144(11):2345-53. PubMed ID: 27018820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
    Kudesia G; Partridge S; Farrington CP; Soltanpoor N
    J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
    Sauerbrei A; Schäfler A; Hofmann J; Schacke M; Gruhn B; Wutzler P
    Clin Vaccine Immunol; 2012 Aug; 19(8):1261-8. PubMed ID: 22718131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
    Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
    J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
    Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
    Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.